EUVIMEDEUVIMED entdecken
Open Access

Clinician-Level Knowledge and Barriers to Hepatocellular Carcinoma Surveillance

Robert J Wong, Patricia D Jones, Bolin Niu, George Therapondos, Mae Thamer, Onkar Kshirsagar, Yi Zhang, Paulo Pinheiro, Beverly Kyalwazi, Ronnie Fass, Mandana Khalili, Amit G Singal

JAMA Network Open · 2024

DOI: 10.1001/jamanetworkopen.2024.11076 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, 2024. Verfasst von Robert J Wong und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Stanford University School of Medicine and Gastroenterology Section, Veterans Affairs Palo Alto Healthca…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, COVID-19, Health Knowledge, Attitudes, Practice. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIMHD NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Surveillance for hepatocellular carcinoma (HCC) in patients with cirrhosis is underused. Identifying potentially modifiable factors to address barriers in HCC surveillance is critical to improve patient outcomes.

Objective

To evaluate clinician-level factors contributing to underuse of HCC surveillance in patients with cirrhosis. Design, Setting, and Participants This survey study included primary care clinicians (PCCs) and gastroenterology and hepatology clinicians at 5 safety-net health systems in the US. Clinicians were surveyed from March 15 to September 15, 2023, to assess knowledge, attitudes, beliefs, perceived barriers, and COVID-19–related disruptions in HCC surveillance in patients with cirrhosis. Data were analyzed from October to November 2023. Main Outcome and Measures HCC surveillance knowledge was assessed with 6 questions querying the respondent’s ability to correctly identify appropriate use of HCC surveillance. Attitudes, perceived barriers, and beliefs regarding HCC surveillance and perceived impact of the COVID-19 pandemic–related disruptions with HCC surveillance were assessed with a series of statements using a 4-point Likert scale and compared PCCs and gastroenterology and hepatology clinicians.

Results

Overall, 347 of 1362 clinicians responded to the survey (25.5% response rate), among whom 142 of 237 (59.9%) were PCCs, 48 of 237 (20.3%) gastroenterology and hepatology, 190 of 236 (80.5%) were doctors of medicine and doctors of osteopathic medicine, and 46 of 236 (19.5%) were advanced practice clinicians. On HCC knowledge assessment, 144 of 270 (53.3%) scored 5 or more of 6 questions correctly, 37 of 48 (77.1%) among gastroenterology and hepatology vs 65 of 142 (45.8%) among PCCs ( P < .001). Those with higher HCC knowledge scores were less likely to report barriers to HCC surveillance. PCCs were more likely to report inadequate time to discuss HCC surveillance (37 of 139 [26.6%] vs 2 of 48 [4.2%]; P = .001), difficulty identifying patients with cirrhosis (82 of 141 [58.2%] vs 5 of 48 [10.4%]; P < .001), and were not up-to-date with HCC surveillance guidelines (87 of 139 [62.6%] vs 5 of 48 [10.4%]; P < .001) compared with gastroenterology and hepatology clinicians. While most acknowledged delays during the COVID-19 pandemic, 62 of 136 PCCs (45.6%) and 27 of 45 gastroenterology and hepatology clinicians (60.0%) reported that patients with cirrhosis could currently complete HCC surveillance without delays. Conclusions and Relevance In this survey study, important gaps in knowledge and perceived barriers to HCC surveillance were identified. Effective delivery of HCC education to PCCs and health system–level interventions must be pursued in parallel to address the complex barriers affecting suboptimal HCC surveillance in patients with cirrhosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsCOVID-19Health Knowledge, Attitudes, PracticeHumansMaleFemaleSARS-CoV-2Middle AgedPractice Patterns, Physicians'Surveys and QuestionnairesUnited StatesAdultPhysicians, Primary CareLiver CirrhosisAttitude of Health PersonnelClinical Competence

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Stanford University School of Medicine and Gastroenterology Section, Veterans Affairs Palo Alto Healthcare System, Palo Alto, California.
  • Division of Digestive Health and Liver Diseases, University of Miami School of Medicine and Jackson Memorial Health System, Miami, Florida.
  • Division of Gastroenterology and Hepatology, MetroHealth Hospital and Health System, Cleveland, Ohio.
  • Multiorgan Transplant Institute, Ochsner Health, New Orleans, Louisiana.
  • Medical Technology and Practice Patterns Institute, Bethesda, Maryland.
  • Division of Epidemiology and Population Health Sciences, University of Miami School of Medicine, Miami, Florida.

Förderung

  • NIDDK NIH HHS
  • NIMHD NIH HHS
  • NCI NIH HHS
  • NIAAA NIH HHS

Zitieren

APA

Wong, R. J., Jones, P. D., Niu, B., Therapondos, G., Thamer, M., Kshirsagar, O., Zhang, Y., Pinheiro, P., Kyalwazi, B., Fass, R., Khalili, M., & Singal, A. G. (2024). Clinician-Level Knowledge and Barriers to Hepatocellular Carcinoma Surveillance. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2024.11076

Vancouver

Wong RJ, Jones PD, Niu B, Therapondos G, Thamer M, Kshirsagar O, et al. Clinician-Level Knowledge and Barriers to Hepatocellular Carcinoma Surveillance. JAMA Network Open. 2024. doi:10.1001/jamanetworkopen.2024.11076

BibTeX
@article{Wong2024,
  author = {Wong, Robert J and Jones, Patricia D and Niu, Bolin and Therapondos, George and Thamer, Mae and Kshirsagar, Onkar and Zhang, Yi and Pinheiro, Paulo and Kyalwazi, Beverly and Fass, Ronnie and Khalili, Mandana and Singal, Amit G},
  title = {Clinician-Level Knowledge and Barriers to Hepatocellular Carcinoma Surveillance},
  journal = {JAMA Network Open},
  year = {2024},
  doi = {10.1001/jamanetworkopen.2024.11076}
}
Kostenlos starten →